Cleared Traditional

K082107 - CLINIQA LIQUID QC URINE CHEMISTRY CONTROLS, LEVELS 1 AND 2

K082107 is an FDA 510(k) clearance for CLINIQA LIQUID QC URINE CHEMISTRY CONTROLS, manufactured by Cliniqa Corporation. The device is a Class 1 Chemistry device with product code JJY cleared through the Traditional 510(k) pathway after a 54-day FDA review.

K082107 · Cliniqa Corporation · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2008
Decision
54d
Days
Class 1
Risk

K082107 is an FDA 510(k) clearance for the CLINIQA LIQUID QC URINE CHEMISTRY CONTROLS, LEVELS 1 AND 2. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Cliniqa Corporation (San Marcos, US). The FDA issued a Cleared decision on September 17, 2008 after a review of 54 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cliniqa Corporation devices

FDA 510(k) Submission Details - K082107

510(k) Number K082107 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2008
Decision Date September 17, 2008
Days to Decision 54 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 88d · This submission: 54d
Pathway characteristics
Predicate-based equivalence.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 593
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K082107.
VALIDATE THYROID CALIBRATION VERIFICATION TEST SET, MODEL 901
K083891 · Maine Standards Co. · Mar 2009
AUDIT MICROCV THERAPEUTIC DRUG (TDM) LINEARITY SET, MODEL K707M-5
K082714 · Aalto Scientific, Ltd. · Nov 2008
AUDIT MICROCV TUMOR MARKERS LINEARITY SET, MODEL K719M-5
K082717 · Aalto Scientific, Ltd. · Oct 2008
LYPHOCHEK TUMOR MARKET PLUS CONTROL LEVEL 1, 2 AND 3 AND MINIPAK
K082036 · Bio-Rad Laboratories · Sep 2008
MSC LIPID CONTROL
K082067 · Maine Standards Co. · Aug 2008
CLINIQA LIQUID QC COMPLETE CARDIAC MARKER CONTROL, LEVELS 1,2, AND 3
K080973 · Cliniqa Corporation · Jun 2008